1. El-Hattab AW, Adesina AM, Jones J, Scaglia F. MELAS syndrome: clinical manifestations, pathogenesis, and treatment options. Mol Genet Metab. 2015; 116:4–12.
2. Cardenas-Robledo S, Saber Tehrani A, Blume G, Kattah JC. Visual, ocular motor, and cochleo-vestibular loss in patients with heteroplasmic, maternally-inherited diabetes mellitus and deafness (MIDD), 3243 transfer RNA mutation. J Neuroophthalmol. 2016; 36:134–140.
3. Holmes S, Male AJ, Ramdharry G, Woodward C, James N, Skorupinska I, et al. Vestibular dysfunction: a frequent problem for adults with mitochondrial disease. J Neurol Neurosurg Psychiatry. 2019; 90:838–841.
4. Iwasaki S, Egami N, Fujimoto C, Chihara Y, Ushio M, Kashio A, et al. The mitochondrial A3243G mutation involves the peripheral vestibule as well as the cochlea. Laryngoscope. 2011; 121:1821–1824.
5. Kim SH, Akbarkhodjaeva ZA, Jung I, Kim JS. Eye movement and vestibular dysfunction in mitochondrial A3243G mutation. Neurol Sci. 2016; 37:1159–1162.
6. Kattah JC. Clinical characteristics and etiology of bilateral vestibular loss in a cohort from central illinois. Front Neurol. 2018; 9:46.
7. Walker MF, Zee DS. Asymmetry of the pitch vestibulo-ocular reflex in patients with cerebellar disease. Ann N Y Acad Sci. 2005; 1039:349–358.
8. Tarnutzer AA, Bockisch CJ, Buffone E, Weiler S, Bachmann LM, Weber KP. Disease-specific sparing of the anterior semicircular canals in bilateral vestibulopathy. Clin Neurophysiol. 2016; 127:2791–2801.
9. Inoue A, Iwasaki S, Fujimoto C, Kinoshita M, Yamasoba T. Progression of peripheral vestibular dysfunctions in patients with a mitochondrial A3243G mutation. Otol Neurotol. 2019; 40:359–364.